4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone

C137H195F4N11O15 — CID 159156999

IUPAC4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone
SMILESCC(C)(C)c1ccc(C(=O)N(CCO)C2CCCCC2)cc1.CC(C)(C)c1ccc(C(=O)N2CCCCC2CO)cc1.CC(C)(C)c1ccc(C(=O)N2CCC[C@H]2CO)cc1.CC(C)(C)c1ccc(C(=O)N2CCOCC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(C(=O)N2CCOCC2)cc1F.CN1CCC(n2cc(NC(=O)c3ccc(C(C)(C)C)cc3)cn2)CC1.COC1CCN(C(=O)c2ccc(C(C)(C)C)cc2)CC1.COC[C@@H]1CCCN1C(=O)c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C20H28N4O.C19H29NO2.3C17H25NO2.C16H20F3NO2.C16H23NO2.C15H20FNO2/c1-20(2,3)16-7-5-15(6-8-16)19(25)22-17-13-21-24(14-17)18-9-11-23(4)12-10-18;1-19(2,3)16-11-9-15(10-12-16)18(22)20(13-14-21)17-7-5-4-6-8-17;1-17(2,3)14-7-5-13(6-8-14)16(19)18-11-9-15(20-4)10-12-18;1-17(2,3)14-9-7-13(8-10-14)16(19)18-11-5-6-15(18)12-20-4;1-17(2,3)14-9-7-13(8-10-14)16(20)18-11-5-4-6-15(18)12-19;1-15(2,3)11-4-5-12(13(10-11)16(17,18)19)14(21)20-6-8-22-9-7-20;1-16(2,3)13-8-6-12(7-9-13)15(19)17-10-4-5-14(17)11-18;1-15(2,3)12-5-4-11(10-13(12)16)14(18)17-6-8-19-9-7-17/h5-8,13-14,18H,9-12H2,1-4H3,(H,22,25);9-12,17,21H,4-8,13-14H2,1-3H3;5-8,15H,9-12H2,1-4H3;7-10,15H,5-6,11-12H2,1-4H3;7-10,15,19H,4-6,11-12H2,1-3H3;4-5,10H,6-9H2,1-3H3;6-9,14,18H,4-5,10-11H2,1-3H3;4-5,10H,6-9H2,1-3H3/t;;;15-;;;14-;/m...0..0./s1
InChIKeyKKAARUQEASGQTK-DOBMCWHYSA-N
MW2312.12 g/mol
LogP25.54
Rot. Bonds18

About 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone

4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone (PubChem CID 159156999) has the molecular formula C137H195F4N11O15 and a molecular weight of 2312.12 g/mol. Its IUPAC name is 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone.

Molecular Properties

Compound Name4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone
PubChem CID159156999
Molecular FormulaC137H195F4N11O15
Molecular Weight2312.12 g/mol
Exact Mass2310.48
IUPAC Name4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone
SMILESCC(C)(C)c1ccc(C(=O)N(CCO)C2CCCCC2)cc1.CC(C)(C)c1ccc(C(=O)N2CCCCC2CO)cc1.CC(C)(C)c1ccc(C(=O)N2CCC[C@H]2CO)cc1.CC(C)(C)c1ccc(C(=O)N2CCOCC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(C(=O)N2CCOCC2)cc1F.CN1CCC(n2cc(NC(=O)c3ccc(C(C)(C)C)cc3)cn2)CC1.COC1CCN(C(=O)c2ccc(C(C)(C)C)cc2)CC1.COC[C@@H]1CCCN1C(=O)c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C20H28N4O.C19H29NO2.3C17H25NO2.C16H20F3NO2.C16H23NO2.C15H20FNO2/c1-20(2,3)16-7-5-15(6-8-16)19(25)22-17-13-21-24(14-17)18-9-11-23(4)12-10-18;1-19(2,3)16-11-9-15(10-12-16)18(22)20(13-14-21)17-7-5-4-6-8-17;1-17(2,3)14-7-5-13(6-8-14)16(19)18-11-9-15(20-4)10-12-18;1-17(2,3)14-9-7-13(8-10-14)16(19)18-11-5-6-15(18)12-20-4;1-17(2,3)14-9-7-13(8-10-14)16(20)18-11-5-4-6-15(18)12-19;1-15(2,3)11-4-5-12(13(10-11)16(17,18)19)14(21)20-6-8-22-9-7-20;1-16(2,3)13-8-6-12(7-9-13)15(19)17-10-4-5-14(17)11-18;1-15(2,3)12-5-4-11(10-13(12)16)14(18)17-6-8-19-9-7-17/h5-8,13-14,18H,9-12H2,1-4H3,(H,22,25);9-12,17,21H,4-8,13-14H2,1-3H3;5-8,15H,9-12H2,1-4H3;7-10,15H,5-6,11-12H2,1-4H3;7-10,15,19H,4-6,11-12H2,1-3H3;4-5,10H,6-9H2,1-3H3;6-9,14,18H,4-5,10-11H2,1-3H3;4-5,10H,6-9H2,1-3H3/t;;;15-;;;14-;/m...0..0./s1
InChIKeyKKAARUQEASGQTK-DOBMCWHYSA-N
XLogP25.54
TPSA289.94 Ų
H-Bond Donors4
H-Bond Acceptors18
Rotatable Bonds18
Heavy Atoms167
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002312.12
LogP ≤ 525.54
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1018

Analyze 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone?
The IUPAC name of 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone (CID 159156999) is 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone.
What is the SMILES notation for 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone?
The canonical SMILES for 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone is CC(C)(C)c1ccc(C(=O)N(CCO)C2CCCCC2)cc1.CC(C)(C)c1ccc(C(=O)N2CCCCC2CO)cc1.CC(C)(C)c1ccc(C(=O)N2CCC[C@H]2CO)cc1.CC(C)(C)c1ccc(C(=O)N2CCOCC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(C(=O)N2CCOCC2)cc1F.CN1CCC(n2cc(NC(=O)c3ccc(C(C)(C)C)cc3)cn2)CC1.COC1CCN(C(=O)c2ccc(C(C)(C)C)cc2)CC1.COC[C@@H]1CCCN1C(=O)c1ccc(C(C)(C)C)cc1.
What is the InChIKey of 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone?
The InChIKey is KKAARUQEASGQTK-DOBMCWHYSA-N. The full InChI is InChI=1S/C20H28N4O.C19H29NO2.3C17H25NO2.C16H20F3NO2.C16H23NO2.C15H20FNO2/c1-20(2,3)16-7-5-15(6-8-16)19(25)22-17-13-21-24(14-17)18-9-11-23(4)12-10-18;1-19(2,3)16-11-9-15(10-12-16)18(22)20(13-14-21)17-7-5-4-6-8-17;1-17(2,3)14-7-5-13(6-8-14)16(19)18-11-9-15(20-4)10-12-18;1-17(2,3)14-9-7-13(8-10-14)16(19)18-11-5-6-15(18)12-20-4;1-17(2,3)14-9-7-13(8-10-14)16(20)18-11-5-4-6-15(18)12-19;1-15(2,3)11-4-5-12(13(10-11)16(17,18)19)14(21)20-6-8-22-9-7-20;1-16(2,3)13-8-6-12(7-9-13)15(19)17-10-4-5-14(17)11-18;1-15(2,3)12-5-4-11(10-13(12)16)14(18)17-6-8-19-9-7-17/h5-8,13-14,18H,9-12H2,1-4H3,(H,22,25);9-12,17,21H,4-8,13-14H2,1-3H3;5-8,15H,9-12H2,1-4H3;7-10,15H,5-6,11-12H2,1-4H3;7-10,15,19H,4-6,11-12H2,1-3H3;4-5,10H,6-9H2,1-3H3;6-9,14,18H,4-5,10-11H2,1-3H3;4-5,10H,6-9H2,1-3H3/t;;;15-;;;14-;/m...0..0./s1.
What are the key properties of 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone?
4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone has a molecular weight of 2312.12 g/mol, XLogP of 25.54, 18 rotatable bonds, 4 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-tert-butyl-N-cyclohexyl-N-(2-hydroxyethyl)benzamide;(4-tert-butyl-3-fluorophenyl)-morpholin-4-ylmethanone;4-tert-butyl-N-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]benzamide;(4-tert-butylphenyl)-[2-(hydroxymethyl)piperidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]methanone;(4-tert-butylphenyl)-(4-methoxypiperidin-1-yl)methanone;[4-tert-butyl-2-(trifluoromethyl)phenyl]-morpholin-4-ylmethanone is sourced from PubChem (CID 159156999), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).